25 May 2013
Keywords: chugai, licenses, japanese, rights, romark, hcv, drug
Article | 23 February 2009
Romark Laboratories, a privately-held US biopharmaceutical company, and Japanese drugmaker Chugai, a unit of Swiss drug major Roche, have
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
23 February 2009
24 May 2013
© 2013 thepharmaletter.com